Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 5—May 2022
Research

Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018

Alba Mir-Cros1, Albert Moreno-Mingorance1, M. Teresa Martín-Gómez, Raquel Abad, Iván Bloise, Magda Campins, Alejandro González-Praetorius, M. Nieves Gutiérrez, Héctor Martín-González, Carmen Muñoz-Almagro, M. Ángeles Orellana, Manuela de Pablos, Josep Roca-Grande, Carlos Rodrigo, M. Elena Rodríguez, Sonia Uriona, M. José Vidal, Tomàs Pumarola, M. Nieves Larrosa, and Juan José González-LópezComments to Author 
Author affiliations: Hospital Universitari Vall d’Hebron Campus, Barcelona, Spain (A. Mir-Cros, A. Moreno-Mingorance, M.T. Martín-Gómez, M. Campins, H. Martín-González, J. Roca-Grande, S. Uriona, T. Pumarola, M.N. Larrosa, J.J. González-López); Universitat Autònoma de Barcelona, Barcelona (A. Mir-Cros, A. Moreno-Mingorance, T. Pumarola, M.N. Larrosa, J.J. González-López); Instituto de Salud Carlos III, Madrid, Spain (R. Abad); Hospital Universitario La Paz, Madrid (I. Bloise, M. de Pablos); Hospital Universitario de Guadalajara, Guadalajara, Spain (A. González-Praetorius, M.E. Rodríguez); Complejo Asistencial Universitario de Salamanca, Salamanca, Spain (M.N. Gutiérrez); Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain (C. Muñoz-Almagro); Universitat Internacional de Catalunya, Barcelona (C. Muñoz-Almagro); CIBER de Epidemiología y Salud Pública, Barcelona (C. Muñoz-Almagro); Hospital Universitario 12 de Octubre, Madrid (M.Á. Orellana); Hospital Universitari Germans Trias i Pujol, Badalona, Spain (C. Rodrigo); Agència de Salut Pública de Catalunya, Barcelona (M.J. Vidal); CIBER de Enfermedades Infecciosas, Barcelona (T. Pumarola, M.N. Larrosa, J.J. González-López)

Main Article

Figure 1

Temporal distribution of pertactin-deficient Bordetella pertussis isolates in Spain, 1986–2018. ACV, acellular vaccine WCV, whole-cell vaccine.

Figure 1. Temporal distribution of pertactin-deficient Bordetella pertussis isolates in Spain, 1986–2018. ACV, acellular vaccine WCV, whole-cell vaccine.

Main Article

1These authors contributed equally to this article.

Page created: March 23, 2022
Page updated: April 19, 2022
Page reviewed: April 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external